Key Record Dates Identifier: NCT03384654
Brief Title: A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

First Submitted : December 20, 2017
First Submitted that Met QC Criteria : December 20, 2017
First Posted : December 27, 2017

Last Update Submitted that Met QC Criteria : September 9, 2021
Last Update Posted : September 10, 2021